Molecule Information
General Information of the Molecule (ID: Mol02226)
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Insulin recombinant
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Type 2 diabetes mellitus | [1] | |||
Resistant Disease | Type 2 diabetes mellitus [ICD-11: 5A11.0] | |||
Resistant Drug | Insulin recombinant | |||
Molecule Alteration | Down-regulation | Interaction |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | HepG2 cells | Liver | Homo sapiens (Human) | CVCL_0027 |
In Vivo Model | Male db/db mice;C57BL/6 mice model | Mus musculus | ||
Experiment for Molecule Alteration |
Microarray assay; Western bloting analysis; Fluorescence in situ hybridization; Overexpression assay; Knockdown assay | |||
Mechanism Description | UC.333 improves IR by binding to miR-223; thus, uc.333 may be a useful target for the treatment and prevention of IR. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.